Literature DB >> 33441319

Human leucocyte antigen association of patients with Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications in Han Chinese.

Kevin Sheng-Kai Ma1,2, Wen Hung Chung3,4,5,6,7,8, Yi-Jen Hsueh2, Shin-Yi Chen9, Katsushi Tokunaga10, Shigeru Kinoshita11, David H K Ma12,13,14,15, Mayumi Ueta16.   

Abstract

BACKGROUND/AIMS: Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) induced by cold medicine (CM) may result in severe ocular complications (SOCs). The purpose of this study was to investigate the human leucocyte antigen (HLA) polymorphism pattern in CM-induced patients with SJS/TEN developing SOCs.
METHODS: All participants, including patients with SJS/TEN (n=33) and control patients (n=98), were enrolled through visits to the clinic from 2016 to 2017. SOCs were diagnosed (n=26) via a chart review or eye examination. Patient saliva was collected with commercialised kits and genotyped with PCR assays followed by hybridisation with sequence-specific oligonucleotide (SSO) probes (PCR-SSO) using commercial bead-based typing kits.
RESULTS: In all patients with SJS/TEN with SOCs, the HLA-A*02:07 carrier frequency was significantly higher than that in controls (OR=3.24, 95% CI=1.09 to 9.60, p=0.049), as was the genotype frequency (OR=3.89, 95% CI=1.49 to 10.16, p=0.007). In patients with CM-SJS/TEN with SOCs, the HLA-A*02:07 carrier frequency was higher than that in controls (OR=5.56, 95% CI=1.52 to 20.00, p=0.016), as was the allele frequency (OR=6.67, 95% CI=2.33 to 20.00, p=0.001). In patients with CM-SJS/TEN with SOCs, the HLA-B*46:01 allele frequency was significantly higher than that in controls (OR=3.85, 95% CI=1.52 to 10.00, p=0.008).
CONCLUSIONS: The HLA-A*02:07 and HLA-B*46:01 alleles were significantly associated with SOCs among Han Chinese patients with CM-SJS/TEN. These findings demonstrate the genetic diversity in SJS pathogenesis among different ethnic groups. © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  conjunctiva; cornea; drugs; genetics; ocular surface

Mesh:

Substances:

Year:  2021        PMID: 33441319     DOI: 10.1136/bjophthalmol-2020-317105

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  6 in total

1.  Human Papillomavirus Infection and the Risk of Erectile Dysfunction: A Nationwide Population-Based Matched Cohort Study.

Authors:  Sin-Ei Juang; Kevin Sheng-Kai Ma; Pei-En Kao; James Cheng-Chung Wei; Hei-Tung Yip; Mei-Chia Chou; Yao-Min Hung; Ning-Chien Chin
Journal:  J Pers Med       Date:  2022-04-27

2.  Clinical Aspects of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications in Taiwan.

Authors:  David Hui-Kang Ma; Tsung-Ying Tsai; Li-Yen Pan; Shin-Yi Chen; Ching-Hsi Hsiao; Lung-Kun Yeh; Hsin-Yuan Tan; Chun-Wei Lu; Chun-Bing Chen; Wen-Hung Chung
Journal:  Front Med (Lausanne)       Date:  2021-05-12

3.  Age-dependent oral manifestations of neurofibromatosis type 1: a case-control study.

Authors:  Eshwar Thota; John Jims Veeravalli; Sai Krishna Manchala; Bhargavi Priya Lakkepuram; Jayasurya Kodapaneni; Yi-Wen Chen; Li-Tzu Wang; Kevin Sheng-Kai Ma
Journal:  Orphanet J Rare Dis       Date:  2022-03-02       Impact factor: 4.123

Review 4.  Findings by an International Collaboration on SJS/TEN With Severe Ocular Complications.

Authors:  Mayumi Ueta
Journal:  Front Med (Lausanne)       Date:  2021-12-01

Review 5.  Susceptibility Genes and HLA for Cold Medicine-Related SJS/TEN with SOC.

Authors:  Mayumi Ueta
Journal:  Front Genet       Date:  2022-07-11       Impact factor: 4.772

6.  Risk of primary Sjogren's Syndrome following human papillomavirus infections: a nationwide population-based cohort study.

Authors:  Huang-Hsi Chen; Kevin Sheng-Kai Ma; Chen Dong; Wen-Jung Chang; Kuan-Rong Gao; Wuu-Tsun Perng; Jing-Yang Huang; James Cheng-Chung Wei
Journal:  Front Immunol       Date:  2022-08-16       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.